Palogic Value Fund Withdraws Nominees and Shareholder Proposal at Pebblebrook Hotel Trust
Key Terms
net asset value financial
ebitda financial
ffo financial
reit financial
deleveraging financial
Highlights Persistent Concerns About NAV Accretion, Executive Accountability, and Economic Alignment
Encourages Board to Explore Asset Sales to Accelerate Share Buyback Program or Consider Sale of Company
February 17, 2026
Pebblebrook Hotel Trust
c/o Corporate Secretary
4747 Bethesda Avenue, Suite 1100
Dear Members of the Board:
Palogic is highly encouraged by the steps Pebblebrook has recently taken to enhance corporate governance. As we have communicated previously, we believe the persistent discount to Net Asset Value (NAV) has been exacerbated by governance issues, specifically regarding extended Board tenures and the alignment of economic incentives.
The addition of directors Nina P.
We acknowledge the professionalism shown by Jon E. Bortz, Raymond D. Martz, Thomas C. Fisher, Cydney C. Donnell, Bonny W. Simi, and Michael J. Schall during our engagement. In recognition of these positive steps, Palogic is formally withdrawing its two director nominees and the shareholder proposal previously submitted for inclusion at the 2026 Annual Meeting of Shareholders.
We Continue to Question Pebblebrook’s NAV Accretion Narrative and Have Significant Capital Allocation Concerns
While we applaud these governance changes, Palogic retains significant concerns regarding the pursuit of NAV accretion, executive accountability, and economic alignment.
Since highlighting the discount to NAV in 2021, the Company has reduced the share count by approximately
Our concerns regarding NAV pursuit remain, and we are hopeful that the refreshed Board will make the following questions a centerpiece of the ongoing strategic discussion and communicate a timely framework to address them:
- Why does the NAV gap exist?
- If NAV accretion is a key priority, why is management not more aggressively pursuing a strategy of acquiring shares?
- What assets could be readily sold to accelerate NAV accretion?
- Would shareholders benefit more from a sale of the entire Company to provide certainty and realize NAV?
The episodic nature of Pebblebrook’s previous buybacks suggests to the market that the Company lacks the financial capacity to pursue NAV accretion without prior deleveraging. Our research indicates deep institutional demand for
To maximize value, the Board must accept that it is difficult to serve "two masters." Prioritizing traditional REIT metrics like FFO and FFO growth may need to be secondary to the massive accretion available by purchasing shares at an approximate
Additionally, while we acknowledge the intangible benefits that come from exiting a market like
We Encourage a Review of Executive Compensation Structure
We also remain concerned by the concentration of decision-making power among Chairman and Chief Executive Officer Mr. Bortz and co-Presidents Mr. Martz and Mr. Fisher. In our opinion, while their institutional expertise is undeniable, the disparity between executive compensation and shareholder outcomes is stark.
-
Mr. Bortz’s total compensation since Pebblebrook went public is
through 2024.$83.7 million -
Mr. Martz and Mr. Fisher have each been compensated close to
through 2024.1$40 million
In our opinion, it is difficult for unaffiliated shareholders to maintain confidence when management is afforded a compensation structure that has not translated into value for the owners of the Company. Despite the approximate
We encourage the Board to review the existing compensation structure to ensure that management is not being incentivized with deeply discounted shares at the expense of unaffiliated shareholders.
Looking Ahead
Given the persistent concerns raised above, we wonder if Pebblebrook’s strategy – focused on full-service, high-barrier to entry coastal markets – would ultimately be better suited for a buyer with a lower cost of capital. The public hotel REIT space has been unforgiving. The corporate strategy may just not align with the current desires of the public markets for portfolios with significantly higher EBITDA margins and less cyclicality, a more consistent corporate theme (e.g., convention/entertainment), or operational leverage and deep relationships with specific brands as the building blocks for value creation. As such, we encourage the Board to consider the sale of the entire Company.
We look forward to seeing how the refreshed Board will challenge the status quo and accelerate the realization of shareholder value.
Respectfully,
Ryan Vardeman, Principal
Scott Williams, Principal
Palogic Value Management, LP
About Palogic
Palogic Value Management, LP, is an investment advisor founded in 2006 that seeks to achieve long-term capital appreciation while limiting the risk of permanent capital impairment by investing in securities the principals believe are trading at a significant discount to intrinsic value, often due to industry dislocation or market misperception of a company’s prospects.
| ____________________ | ||
(1) |
Total compensation as disclosed in Pebblebrook’s Annual Proxy Statements from the years 2009 to 2025 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260217223731/en/
Investor Contact
Ryan Vardeman
pr@palogicfund.com
Media Contact
August Strategic Communications
Palogic-August@AugustCo.com
Source: Palogic Value Management, LP